(Q33832185)

29 July 2017

1 reference

title

The prostate: diagnostic evaluation of metastatic disease (English)

1 reference

29 July 2017

Yu KK

1

1 reference

29 July 2017

Hawkins RA

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Radiologic Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

139-57, ix

1 reference

The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Advanced prostatic carcinoma: pulmonary manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Chest radiography in patients with early stage prostatic carcinoma. Effect on treatment planning and cost analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

CT screening for comorbid disease in patients with prostatic carcinoma: is it cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Cat scanning in staging of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Percutaneous fine-needle biopsy of radiographically normal lymph nodes in the staging of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Brain metastasis as a sole recurrence of prostate cancer after total prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

PET in oncology: will it replace the other modalities?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Positron emission tomography in urological oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Which patients with prostatic carcinoma require a staging bone scan?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Technetium-99M polyphosphate bone scanning in carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Mediastinal metastases from prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Prostatic Carcinoma: Incidence and Location of Unsuspected Lymphatic Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

The Impact of Current Staging Procedures in Assessing Disease Extent of Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Carcinoma of the prostate: a model for management under impending health care system reform. 1994 RSNA annual oration in radiation oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Detection of circulating prostatic cells during radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Nodal involvement as a prognostic indicator in patients with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Lymphangiography combined with biopsy and computer tomography to detect lymph node metastases in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Small cell and anaplastic prostate cancer: correlation between CT findings and prostate-specific antigen level

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

CT evaluation of lymph node status at presentation of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Patterns of lymphatic metastases at recurrence of prostate cancer: CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Pelvic adenopathy from bladder and prostate carcinoma: detection by rapid-sequence computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Computed Tomographic Evaluation of Bone Metastases in Prostatic Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Reliability of Bone Marrow Acid Phosphatase as A Parameter of Metastatic Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8389%2805%2970153-6

7 January 2021

10.1016/S0033-8389(05)70153-6

Identifiers

DOI

1 reference

29 July 2017

1 reference